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Leiomyosarcoma of the rectum is a very rare mesenchymal tumor. Because of its rarity, its diagnosis, treatment, and
pathology often present challenges to the clinician. The characteristics of this tumor, such as its anatomical
location, heterogeneous solid features on imaging, and nonspecific lower gastrointestinal tract symptoms, can be
confused with those of primary ovarian carcinoma. Here, we report the case of a 52-year-old-woman presenting
with a low abdominal mass that was later pathologically confirmed to be a rectal leiomyosarcoma. The findings of
preoperative ultrasonography, pelvic magnetic resonance imaging, and abdominopelvic computed tomography
were suggestive of a malignant pelvic mass, most likely a primary ovarian carcinoma. The patient underwent
explorative laparotomy, and intraoperative frozen examination revealed a sarcoma originating from the
gastrointestinal tract. Low anterior resection and supracervical hysterectomy with bilateral salpingo-oophorectomy
were performed. The patient’s postoperative course was uneventful, and adjuvant chemotherapy is currently being
administered.
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Rectal leiomyosarcoma is an uncommon malignancy ac-
counting for less than 0.1% of all malignancies of the colon
and rectum [1]. These tumors typically occur in the fifth
and sixth decades of life and show a male predominance
[2]. The presenting symptoms are rectal pain, constipation,
rectal fullness, and diarrhea, although some patients may
be asymptomatic [3]. According to the literature, most
rectal leiomyosarcomas are identified as protruding masses
during colonoscopic examination and are confirmed histo-
logically [4-6]. However, if they are not detected by endo-
scopic examination, an accurate diagnosis may be difficult
because their clinical presentation can mimic that of
primary ovarian carcinoma. Here, we report the case of a
woman who had a large pelvic mass that was suggestive of
a primary ovarian malignancy but was finally proven to be
a leiomyosarcoma of the rectum.Case description
A 52-year-old woman (gravida 6, para 1) presented to the
gynecology clinic at Guro Hospital, College of Medicine,* Correspondence: jhhong93@korea.ac.kr
Department of Obstetrics and Gynecology, Guro Hospital, College of
Medicine, Korea University, Seoul 152-703, Republic of Korea
© 2013 Ouh et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orKorea University, with a complaint of low abdominal pain.
In addition to low abdominal pain, the patient had experi-
enced low back pain, urinary frequency, and tenesmus for
approximately 1 year. She had undergone myomectomy 2
years previously in China.
The patient’s menses had ceased at the age of 50. She
had no complaints of vaginal bleeding or low abdominal
distension. She has never undergone a cervical screening
test. On pelvic examination, the cervix was found to be
small, and no specific abnormalities were observed. On
physical examination, a hard mass with an irregular
surface was palpable. A Pap smear and a HC2 test were
performed. The Pap smear result was a low-grade squa-
mous intraepithelial lesion, and The HC2 test result was
negative for high-risk human papillomavirus. Transvaginal
ultrasonography examination revealed an approximately
11-cm mixed echogenic solid mass of the left adnexa,
which strongly suggested the presence of a malignant
tumor (Figure 1). However, serum CA 125 (6.9 U/mL), CA
19–9 (10.8 U/mL), CEA (<0.5 ng/mL), AFP (2.5 ng/mL),
and beta-hCG (2.3 mIU/mL) levels were not elevated. The
findings of chest radiography, mammography, and breast
sonography were normal. An endoscopic examination of
the stomach and colon showed no evidence of metastasis.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Transvaginal ultrasound showing mixed echogenic,
solid mass, measuring 10.6 × 7.3 cm.
Figure 2 Pelvic magnetic resonance imaging scan of T2-
weighted image. The mass shows iso- to slightly low signal
intensity with heterogeneous enhancement. The uterus and sigmoid
colon were displaced anteroinferiorly.
Figure 3 18F-fluorodeoxyglucose positron emission
tomography/computed tomography scan showing a huge
pelvic mass with heterogeneous metabolism.
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cause of stenosis of the lumen, and the rectal mucosa
protruded into the lumen, probably because of extrinsic
compression by the pelvic mass. Pelvic MRI and CT of the
abdomen and pelvis revealed an approximately 12.4-cm
heterogeneous solid mass occupying the entire pelvis and a
portion of the lower abdominal cavity. This mass also
showed internal degeneration and hemorrhagic change,
findings strongly suggestive of a primary ovarian malig-
nancy (Figure 2). The mass was abutted to the posterior
sigmoid colon, whereas the presence of direct invasion
was indeterminate. The uterus displayed an approximately
1-cm well-defined mass that was suggestive of leiomyoma,
but both ovaries were not delineated. On 18F-FDG PET/
CT, a large pelvic mass with heterogeneous metabolism
was identified, suggesting the presence of a malignant mass
(Figure 3). No specific finding suggestive of metastasis was
observed.
Explorative laparotomy with a supraumbilical incision
was performed. A large mass with a longest diameter of
approximately 20 cm was identified. This mass was located
in the cul-de-sac and was densely adhered to the rectum,
retroperitoneal surface, and posterior uterine body. The
uterus and both ovaries and tubes were normal on gross
appearance. A portion of the mass was subjected to frozen
examination, and the result was a mesenchymal tumor
originating from the gastrointestinal tract, such as a gastro-
intestinal stromal tumor. We then performed supracervical
hysterectomy and bilateral salpingo-oophorectomy. After
the completion of gynecologic surgery, a surgical team
from the department of colorectal surgery subsequently
performed anterior resection of the colon and appendec-
tomy. The operation was uneventful, and the patient was
transferred to the department of colorectal surgery after
the operation.Histopathological analysis of the full specimen revealed a
grade 3 leiomyosarcoma, 22 × 17 × 6 cm3 in size, with free
mucosal resection margins. The mitotic count was ≥20
per 10 high-power fields, and an area of necrosis was iden-
tified. The tumor cells had characteristically elongated,
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to pale cytoplasm (Figure 4). On immunohistochemical
staining, the tumor cells were positive for smooth muscle
actin, desmin, and CD99 but negative for S-100 protein
and CD34, consistent with a diagnosis of rectal leiomyo-
sarcoma. The resected appendix also showed the presence
of a metastatic leiomyosarcoma. The uterus and both
adnexa were free of metastasis. Postoperatively, the patient
underwent adjuvant chemotherapy with cyclophospha-
mide, vincristine, and doxorubicin.
Discussion
Leiomyosarcomas account for 10–20% of all soft tissue
sarcomas. They arise most frequently from the uterus,
gastrointestinal tract, and retroperitoneal region [7]. Those
originating from the rectum are very uncommon, and ac-
count for less than 0.1% of all colorectal malignancies [1].
Radiological differentiation between leiomyosarcomas
and leiomyomas is difficult, and the final diagnosis needs
to be confirmed by postoperative pathological examination.
Histological analysis of superficial biopsy samples might
not reflect the entire tumor mass and leiomyosarcoma can
be misdiagnosed as benign leiomyomas. In addition, malig-
nant potential can be missed on CT of MRI. Given that
leiomyosarcoma has a very poor prognosis, misdiagnosis
may give a detrimental effect on patient outcome. In this
case, all preoperative evaluations, excluding those of serum
tumor markers, identified primary ovarian cancer as the
most probable diagnosis. To this point, no specific tumor
markers have exhibited clinical utility for the diagnosis of
leiomyosarcomas. In one series of 10 cases of colorectal
leiomyosarcomas, 9 of 10 patients had lobulated tumor
margins on CT or MRI [8]. Except in the case of 1 patient,
the tumors appeared to be heterogeneous with varying
degrees of internal necrosis, findings consistent with thoseFigure 4 Microscopic appearance of the resected tumor. Tumor
cells had characteristically elongated, pleomorphic, and blunt-ended
nuclei and eosinophilic to pale cytoplasm.of our case. In 1 patient for whom MRI data were available,
the tumor appeared to have intermediate signal intensity
on T2-weighted images with heterogeneous contrast en-
hancement. In another case of rectal leiomyosarcoma, MRI
demonstrated a mass of uniform, intermediate signal inten-
sity on T1-weighted images, and heterogeneous high signal
intensity on T2-weighted images. Irregular enhancement
occurred after intravenous gadolinium [9]. Unfortunately,
the aforementioned findings are also commonly encoun-
tered in patients with ovarian carcinomas. Therefore,
preoperative radiological differentiation between ovarian
carcinoma and rectal leiomyosarcoma is difficult.
A distinguishing feature of our case is that the rectal
tumor mass was not identified on total colonoscopy. Gen-
erally, colonoscopic examination including sigmoidoscopy
shows a polypoid, submucosal mass occupying the lumen,
leading to the suspicion of a tumor originating in the
rectum. In such cases, rectal bleeding or obstruction can
occur, prompting an evaluation of the possibility of colo-
rectal problems. However, some rectal leiomyosarcomas
growing away from the lumen, so-called exocolic growth,
may not be detected on colonoscopic examination. The
growth pattern of the tumor and the lack of specific symp-
toms might be responsible for the failure of preoperative
diagnosis.
Pathologically, leiomyosarcomas can be distinguished
from leiomyomas on the basis of the following features:
larger tumor cells, fewer stromal fibers, increased mitotic
activity, and nuclear pleomorphism [10]. Among these
findings, the presence of mitoses is the hallmark of malig-
nancy (5 or more mitoses per 10 high-power fields) [11].
The spread of rectal leiomyosarcoma is mainly local or
hematogenous, although lymphatic metastasis has been
reported in some poorly differentiated tumors [8]. In our
case, no metastasis was found in resected perirectal lymph
nodes. The optimal treatment modality in patients
with rectal leiomyosarcomas is controversial. Wide local
excision and radical surgery, such as anterior resection
or abdominoperineal resection, are commonly used. As
shown in many studies, radical surgery is associated with a
lower recurrence rate than wide local excision [2,12].
However, differences in survival rates were not statistically
significant, regardless of the treatment modality [2,12].
Pelvic radiation therapy is generally considered unsuccess-
ful. Minsky et al. reported moderate success using radiation
therapy following surgery [13]. In contrast, Consentino
et al. demonstrated that neither adjuvant radiation therapy
nor chemotherapy is effective [14]. Chemotherapy has been
generally unsuccessful in treating this tumor. The 2 most
commonly used agents, doxorubicin and dacarbazine, are
associated with low response rates ranging from 15% to
30% [15]. Unfortunately, there are few data regarding the
efficacy of adjuvant treatments in the literature to draw de-
finitive conclusions. The overall prognosis is poor, with
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additional mortality reported during later years [16]. Tumor
size and the degree of differentiation are known to be the
most significant prognostic factors.
Conclusion
In this study, we presented a case of rectal leiomyosarcoma
mimicking primary ovarian carcinoma. We can draw a
lesson from this case report. When a woman presents with
a pelvic mass that is suggestive of ovarian carcinoma on
radiological evaluation but is suggestive of ovarian cancer
on the basis of normal serum tumor marker levels, the
possibility of rectal leiomyosarcoma should be suspected
even in the absence of rectal bleeding or pain. We also cau-
tion that appropriate surgical treatment should not be
delayed solely on the basis of normal tumor marker levels.
Because of its poor prognosis, early diagnosis and prompt
surgical removal are important for patients with rectal
leiomyosarcoma.
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